
Please try another search
3-D Matrix, Ltd. develops self-assembling peptide technology in Japan and internationally. It offers PuraMatrix, a self-assembling peptide hydrogel for use in the regenerative medicine, cell therapy, drug delivery systems, and other uses in various fields. The company was incorporated in 2004 and is based in Tokyo, Japan.
Name | Age | Since | Title |
---|---|---|---|
Kazuharu Tsuboi | 46 | 2015 | Director |
Jun Okada | 50 | 2007 | President, CEO & Representative Director |
Keiji Nagano | 70 | 2004 | Executive Chairman of the Board |
Satoru Kobayashi | 44 | 2017 | Executive Officer, Head of Business Development & Director |
Robert S. Langer | 76 | - | Medical, Science & Technology Adviser |
Tatsutoshi Nakahata | - | - | Medical, Science & Technology Adviser |
Takashi Noguchi | - | - | Medical, Science & Technology Adviser |
Mamoru Nomura | - | - | Medical, Science & Technology Adviser |
Noriyuki Okawara | 55 | 2023 | Outside Auditor |
Ikkei Matsuda | 63 | - | Medical, Science & Technology Adviser |
Bengt Norden | - | - | Medical, Science & Technology Adviser |
Kazuya Shimamura | 53 | 2012 | Independent External Director |
Yoshiaki Harino | - | - | Medical, Science & Technology Adviser |
Toshi Amanuma | 50 | 2020 | Director |
Ryuhei Mogi | 58 | 2023 | Director |
Takeshi Takemoto | 69 | 2024 | Full-time Statutory Auditor |
Koichiro Ito | 53 | 2024 | Outside Auditor |
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review